GL1X · GenesisL1 explorer

MolNFT v1 · #164919 · protein

Crystal structure of the disulfide engineered HLA-A0201 molecule in complex with one gl dipeptide in the a pocket.

6TDP · MHC class I antigen: “Crystal structure of the disulfide engineered HLA-A0201 molecule in complex with one gl dipeptide in the a…”. X-ray diffraction, 1 ligand (NA), 5 pockets (best druggability 0.69). MolNFT v1 #164919 on…

PDB
6TDP
Type
protein
Length
375 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
MHC class I antigen; Beta-2-microglobulin
UniProt
F6IQS1, P61769
Ligands
NA
Pockets
5 · best druggability 0.69

Structure

x-ray diffraction · 2 distinct chains · 19% helix, 43% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMHC class I antigenprotein27626% helix, 40% strandF6IQS1
BBeta-2-microglobulinprotein990% helix, 49% strandP61769

Ligands and binding sites

  • NA · Sodium ion · metal · chains A
  • GOL · Glycerol · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16400.690.7757GOL
2950.470.8122empty
31680.470.7527GOL
4980.430.7822empty
5890.390.7715empty

Interfaces

1 interface between chains.

  • A–B · 1304 Ų buried · 20 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 6TDP · Crystal structure of the disulfide engineered HLA-A0201 molecule in complex with one GL… · the same entry in another collection · chain A against A, TM-score 1.00
  • P61769 · AlphaFold monomer V2.0 prediction for beta-2-microglobulin (P61769) · a predicted model of the same protein · chain B against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.